||EPS - Basic
||Market Cap (m)
Real-Time news about Wyatt Group (London Stock Exchange): 0 recent articles
|tiredoldbroker: Let's revisit what toss-pot Treacle said about this stock:
"Treacle28 - 10 Aug'08 - 20:03 - 519 of 531
Just 25K available at 4.20p at close on Friday and then 4.45p for higher amount. Not many shares in free float though. Think some Independent readers will have a speculative punt tomorrow with mkt capt only 0.60m. With all the disposals now made the next set of figures will be extremely positive on 2-3m minimum turnover and 500K minimum gross profit (20p at Interims in December with 2.80m mkt capt). Plus, one more acquisition coming. May well be RTO as pursued last summer."
Yes, Treacle being as "accurate" as ever - those two forecasts of "next set of figures will be extremely positive... 500K minimum gross profit" and "20p at Interims in December" contrast so fundamentally with the £371K pre tax loss and share price of just 1.5p bid. No wonder Treacle's gone quiet.|
|tiredoldbroker: Poor old Treacle, tries everything to ramp it up over the weekend, gives up going out and having a life to scour the net for something to post here, and the share price goes down!
Guess Treacle must be at least £60 down on this penny punt by now, that's a lot of money off a fortnightly giro.|
|treacle28: Well summarised and good number of positives and highlighting that a hell of a lot more upside potential than downside at current mkt capt and share price:-hopefully may bring in some buyers next week. The 5 year chart shows another one of those 150-200% spikes is due imo!
But two encouraging developments last week left the impression that the shares have, even in today's depressed market, been overlooked. The group has accomplished what looks like a rewarding deal and another is in the pipeline. It also produced figures rather better than I expected.
Indeed, there is a reasonable case for hanging on.
The last right issue was in January 2005, raising around £600,000 at 18p and all the participants have held their shares. A rights issue for an acquisition which would transform the company (similar deal talks failed last summer) would also bring more positives even though they would be issuing more shares imo. Only 14m shares in issue!
The percentage of AIM securities which are in issue that are not in public hands is 52.75%
Institution Interest Percentage
Ruffer LLP 2,676,000 19.03
Dartington Portfolio Nominees Ltd 2,041,887 14.52
Mr Bob Holt 1,112,556 7.91
Mr Ian Rummels 1,066,086 7.58
Noble Fund Managers Ltd 500,000 3.55
AXA S.A 449,444 3.20
Shareholding data last updated on 14th July 2008
|tiredoldbroker: Poor old Treacle, not got anything useful to say, not got any honest answers, so reduced to imagining that other people deal in the same penny packets he does ! I wouldn't even waste £40 on WYT, the share price is not going up.|
|tiredoldbroker: Yeah but Treacle the problem is, you expected the share price to go up ahead of the figures; then on the figures; then after the figures; and you're wrong every time !
The balance sheet is shot to bits, the company will be lucky to remain in profit at the pre tax level this year, there's nothing to go for.|
|tiredoldbroker: Of course, Cancer6/Treacle28 was claiming the share price would go up ahead of the figures... then on the figures... then after the figures... now 'soon' but in the future... and all the time, ignoring the company saying its only profitable business "was hit by a change in tax legislation at the end of 2007 which will have a significant adverse affect on Group's trading in the current year"; a 25% drop in gross profit and the group is lossmaking in the current year, at the pre tax level.|
|tiredoldbroker: "Lord" Santafe, do stop posting such drivel. What you've actually said above is that apart from FPS, nearly all Cancer6's stock picks have gone down the pan; yet your conclusion is that 'he knows what he's talking about' ! Can't you see that you're contradicting yourself and talking sheer nonsense? No wonder you were apparently made bankrupt earlier this year as a result of your disastrous stock picking over the last few years.
And as far as FPS goes, the accounts may show that the company has cash; but it's along way between that and the shareholders seeing any of it. They have just over £1m in Jersey and forecast their overheads for 2008 as about £730,000; that might leave them £300,000 in January 2009, if they don't just blow the lot; and if they get into hassle with the Chinese authorities, you can write off any hope of extracting funds from China. Every chance that the shareholders will get less than the suspension price.
And have you even tried to work out the state of WYT's balance sheet after the closures, mothballing and sale to management they've done in the last year or so ? There's simply not enough left in WYT to support their debt, their battered balance sheet, and the vastly higher share price Cancer6 keeps telling fairies about.|
|drain: In my post 173 before the results I estimated an eps in the second half of the year of 1.43p pre-tax; as it turned the actual figure was 1.31p( taking out the loss of .35p in the first half).The operating charges were higher than I expected, maybe something to do with Wyatt Biotech.
Anyway annualised profits with a P/e of 20 and tax of 30% gives a price of 36.7p. The share price therefore has the potential to nearly double.|
|chancer6: What valuation i.e. share price would you put on these now CurryPasty?|
No Pain, No Gain: My offbeat gamble is paying off in the long run
By Derek Pain
Published : 02 April 2005
Wyatt, an online risk consultancy, celebrates two years as a constituent of the No Pain, No Gain portfolio this month. I cannot pretend it has been an outstanding investment. Against a buying price of 27.5p, the shares are bumping along at 34.5p. Not bad, but not great.
Timing is an important element in the investment game. It is even more essential to get it right when alighting on a small company.
Clearly, I was ahead of events two years ago. But after an uncomfortably long period in the doldrums, with the shares hitting 19p, there is growing evidence that my faith will be justified and little Wyatt will at last log on to the sort of success I anticipated.
The shares have enjoyed a run recently on the back of an intriguing deal with a US company Fingerprint Biotech. Wyatt, it seems, is about to import the US group's drug-testing kits into the UK and Ireland. The kits, which do not need an Einstein to operate, can detect up to nine drugs in two minutes and also take fingerprints.
Three police forces are already interested. I believe other deals are in the pipeline, as Wyatt increases its presence in its specialised markets.
When I recruited the shares, I described them as offbeat and highly speculative - not the usual fodder for my portfolio. Without doubt, the proverbial widows and orphans should avoid them. Yet I felt then - and still do - that they could add a little unadorned excitement to proceedings and would, in the long term, prove to be a winner.
The company provides a range of consultancy services. Firesmart, offering fire-risk advice, is at the forefront of its operations. It is also involved in health services and employment legal and tax advice. Now comes drug testing and fingerprinting. I do not know what other deals are lurking on the horizon. But Wyatt is determined to emerge as a rounded operation which, if it has got its sums right, will prosper in this increasingly bureaucratic and high-tech age.
There is little doubt that the calculations have been pored over again and again. Chairman and leading light is Bob Holt, the man who steered Mears, the support services group, to unexpected riches. With Mears jogging along without an apparent care in the world, I suspect his thoughts will turn increasingly to his second string - Wyatt.
and leading light is Bob Holt, the man who steered Mears, the support services group, to unexpected riches. With Mears jogging along without an apparent care in the world, I suspect his thoughts will turn increasingly to his second string - Wyatt.
Indeed, if only some of the Holt success rubs off onto the online consultancy, then the shares should make heady progress. After all, Mears, which specialises in the social housing market, should produce profits of £10m this year - more than double what it made in 2003. And its shares have enjoyed a staggering run since arriving on the stock market some eight years ago. They were floated at 10p; today they are not far short of 250p.
I believe a significant acquisition is being prepared. Mears has the firepower to buy a major rival in what is still a fragmented industry. The shares are currently traded on the junior Alternative Investment Market.
A move to the main market and admission to the FTSE 250-share index seem to be part of the group's longish-term plan. When I alighted on Wyatt, I unashamedly admitted that it was Bob Holt's presence that attracted me. The former Tottenham Hotspur executive has developed Mears with an uncanny instinct for success; I believe that he is capable of repeating at least some of the magic at Wyatt.
The yearly results from portfolio constituent MacLellan, which I touched upon last week, suffered from a tortuous raft of one-off special charges. Before exceptionals were taken into account, its profits were up £1.2m at £6.7m. But then an array of costs checked in to reduce the "true" pre-tax profits to £1.5m, down from £3.3m. One exceptional item relates to a dispute over the ending of two contracts and should, if only in part, be recoverable.
The cleaning-to-security group, which has adopted an aggressive acquisition policy, seems confident about the current year's progress and underlined its optimism by increasing the year's dividend to 1p a share from 0.75p. But the payment leaves it in the red.
These figures will not deter any determined predator. The group's recent rejection of one bidder may have alerted other interested parties. It is said the talks were aborted after MacLellan's chairman, Bob Morton, refused to lower his valuation of 100p a share.
Indeed, with MacLellan looking stronger after a difficult year, it will be seen as a takeover candidate by the stock market. That should do no harm to the share price, which has certainly been something of a disappointment since I recruited the shares in 2001.|
Wyatt share price data is direct from the London Stock Exchange